PARIS — Among patients with complex coronary artery disease (CAD) who required de novo revascularization, those with three-vessel disease had better 10-year survival after coronary artery bypass ...

Investigators from the EXCEL trial have doubled down on the July publication of their study's outcomes based on an alternative definition of myocardial infarction (MI) resulting from coronary ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio PARIS — Ten-year follow-up data from the ...

At 5 years, women with who received PCI were significantly more likely to die than those who received CABG (adjusted HR 0.38; 95% CI 0.17-0.87), although no such difference was observed in men.

PARIS, France—The full and final 10-year results from the SYNTAX Extended Survival Trial (SYNTAXES) suggest that CABG confers a mortality advantage over PCI for patients with three-vessel disease, but ...

SAN DIEGO — In preliminary 10-year results of the SYNTAXES study presented at TCT 2018, there was no significant difference in survival between patients who had CABG and those who had PCI with a first ...